Last viewed: abbv

Prices are updated after-hours

Abbv Nyse

AbbVie Inc.

ABBV | $165.45 0.73% 140K

|

Health Technology

(0.0% 1d) (-8.8% 1m) (1.7% 1y) (0.0% 2d) (0.9% 3d) (-0.2% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 292,953,543,337
http://www.abbvie.com
Sec Filling | Patents | 30000 employees

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

cancer hiv autoimmunity hepatitis fibrosis metabolic parkinson neurological

Drugs

Alcohol - Hand Sanitizer (Alcohol)
Androgel (Testosterone)
Creon (Pancrelipase)
Depakote (Divalproex Sodium)
Depakote ER (Divalproex Sodium)
Depakote Sprinkles (Divalproex Sodium)
Duopa (Carbidopa and Levodopa)
Gengraf (Cyclosporine)
Humira (Adalimumab)
Kaletra (Lopinavir and Ritonavir)
K-Tab (Potassium Chloride)
Lupaneta Pack (leuprolide acetate and norethindrone acetate)
Lupron Depot (leuprolide acetate)
Lupron Depot-PED (leuprolide acetate)
Marinol (Dronabinol)
Mavyret (Glecaprevir and Pibrentasvir)
Niaspan (Niacin)
Nimbex (Cisatracurium besylate)
Norvir (Ritonavir)
Oriahnn (Elagolix and Estradiol and Norethisterone)
Orilissa (Elagolix)
Rinvoq (Upadacitinib)
Skyrizi (Risankizumab-rzaa)
Survanta (Beractant)
Synthroid (Levothyroxine Sodium)
Tarka (Trandolapril and Verapamil Hydrochloride)
Tricor (Fenofibrate)
Trilipix (Fenofibric Acid)
Ultane (Sevoflurane)
Venclexta (Venetoclax)
Viekira Pak (Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir)
Zemplar (Paricalcitol)

add to watch list Paper trade email alert is off

Press-releases

Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027, Technavio
Published: 2024-04-17 (Crawled : 00:00) - prnewswire.com
ABBV | $165.45 0.73% 140K

|

Health Technology

| 0.0% | O: 0.75% H: 0.0% C: 0.0%
AMGN | $263.54 -0.2% 80K

|

Health Technology

| 0.0% | O: -0.75% H: 0.0% C: 0.0%
therapeutics market

Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 0

|

Health Technology

| -0.29% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | $140.15 3.58% 0

|

Health Technology

| -0.47% | O: 2.1% H: 0.0% C: -2.52%
NVS | News | $93.08 -0.13% -0.04% 670

|

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
GSK | $39.39 -0.53% 140K

|

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
BAX | News | $39.38 -0.35% 110K

|

Health Technology

| -0.85% | O: -0.1% H: 0.13% C: -1.08%
ABBV | $165.45 0.73% 140K

|

Health Technology

| 1.39% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $46.11 0.68% 0.7% 66K

|

Health Technology

| -1.62% | O: -2.13% H: 0.0% C: 0.0%
BMRN | News S | $90.47 -0.44% -0.43% 610

|

Health Technology

| -0.46% | O: -0.72% H: 0.0% C: 0.0%
AZN | $68.41 -0.18% 340K

|

Health Technology

| -0.68% | O: -0.64% H: 0.45% C: -0.04%
AMGN | $263.54 -0.2% 80K

|

Health Technology

| 0.54% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 0

|

Health Technology

| -0.22% | O: -0.53% H: 0.61% C: 0.61%
JNJ | News | $144.77 0.22% 0.4% 130K

|

Health Technology

| -2.32% | O: -0.04% H: 0.0% C: 0.0%
ABBV | $165.45 0.73% 140K

|

Health Technology

| -0.23% | O: 0.13% H: 0.11% C: -1.73%
SNY | News | $46.11 0.68% 0.7% 66K

|

Health Technology

| 0.29% | O: 1.95% H: 0.0% C: 0.0%
research global gastrointestinal therapeutics

AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | $165.45 0.73% 140K

|

Health Technology

| -2.15% | O: -1.92% H: 0.0% C: 0.0%
qulipta abbvie treatment for migraine

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 0.63% -2.18% 0

|

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $140.15 3.58% 0

|

Health Technology

| 1.57% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.15 0.45% 77K

|

Health Technology

| -5.93% | O: -0.25% H: 1.1% C: -0.17%
NVS | News | $93.08 -0.13% -0.04% 670

|

Health Technology

| -2.83% | O: -0.05% H: 0.43% C: -0.27%
BMY | $47.84 370K

|

Health Technology

| -5.96% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.435 -2.6% 140K

|

Health Technology

| -16.04% | O: 0.38% H: 0.0% C: -7.27%
ABBV | $165.45 0.73% 140K

|

Health Technology

| -2.38% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.11 0.68% 0.7% 66K

|

Health Technology

| -1.74% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.41 -0.18% 340K

|

Health Technology

| 1.21% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ABBV | $165.45 0.73% 140K

|

Health Technology

| -2.38% | O: 0.77% H: 1.63% C: 0.35%
CHRS | $2.145 -0.23% 58K

|

Health Technology

| -11.52% | O: 0.82% H: 3.88% C: 2.45%
chs-1000 preclinical for meeting

AbbVie to Host First-Quarter 2024 Earnings Conference Call
Published: 2024-04-04 (Crawled : 12:00) - prnewswire.com
ABBV | $165.45 0.73% 140K

|

Health Technology

| -9.44% | O: -1.86% H: 0.03% C: -5.49%
conference abbvie

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NXGL | $2.255 4.4% -1.4% 0

|

| -17.58% | O: 1.83% H: 0.0% C: -19.42%
ABBV | $165.45 0.73% 140K

|

Health Technology

| -9.98% | O: -0.12% H: 0.01% C: -0.62%
year revenue

Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
AMGN | $263.54 -0.2% 80K

|

Health Technology

| Email alert Add to watchlist
GMAB | $28.29 -0.84% 21K

|

Health Technology

| Email alert Add to watchlist
GILD | $66.33 -0.9% 520K

|

Health Technology

| Email alert Add to watchlist
SNY | News | $46.11 0.68% 0.7% 66K

|

Health Technology

| Email alert Add to watchlist
ABBV | $165.45 0.73% 140K

|

Health Technology

| Email alert Add to watchlist
BMY | $47.84 370K

|

Health Technology

| Email alert Add to watchlist
NVS | News | $93.08 -0.13% -0.04% 670

|

Health Technology

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K

|

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 0.63% -2.18% 0

|

Health Technology

| Email alert Add to watchlist
GNMSF | $281.02 -1.44% 0

|

Health Technology

| Email alert Add to watchlist
research global leukemia therapeutics market

Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Advancements in Containment Technologies, and Increasing Investment for Manufacturing Units
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
ABBV | $165.45 0.73% 140K

|

Health Technology

| -9.11% | O: 0.36% H: 0.72% C: 0.61%
research global

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001415889-24-006165	4	2024-03-01	2024-02-23	Sell	M	14140	17380
0001415889-24-006165	4	2024-03-01	2024-02-28	Sell	F	11634	15431
0001415889-24-006165	4	2024-03-01	2024-02-23	Sell	S	14140	27065
0001415889-24-006165	4	2024-03-01	2024-02-23	Buy	M	14140	41205

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

51%

49%

Top 10 Gainers

AGBA | $1.44 260.0% 40M

|

BPTH | $6.25 92.9% 20M

|

Health Technology

EGOX | $0.0447 39.25% 24M

|

ALRN | $5.67 33.41% 110K

|

Health Technology

HOLO | $2.765 23.44% 17M

|

BNTC | $5.91 23.13% 1.3M

|

Health Technology

XPON | $2.33 20.73% 410K

|

BRSH | $0.0515 15.99% 12M

|

VTNR S | $1.12 14.38% 470K

|

Industrial Services

GGE | $0.0332 13.7% 18M

|

Last 48 Hours Insiders Buying

RELL | $9.86 -0.4% -0.41% 1

|

Electronic Technology

| 13:30
IZEA | $2.53 1.2% -2.4% 0

|

Technology Services

| 00:00
RKT P 383 | $11.38 -0.52% 2.64% 5

|

| 22:30
CTRN P 18090 | $22.34 -0.13% 8.1K

|

| 22:00
BRN P 10650 | $2.79 2.2% 0.0% 0

|

Energy Minerals

| 21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 0

|

Health Technology

| 16:30
RMCF | $3.53 -3.16% -3.85% 0

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar